|
WO1999015179A1
(en)
|
1997-09-25 |
1999-04-01 |
Regents Of The University Of Minnesota |
Methods of limiting apoptosis of cells
|
|
US6184210B1
(en)
|
1997-10-10 |
2001-02-06 |
Cytovia, Inc. |
Dipeptide apoptosis inhibitors and the use thereof
|
|
CA2319131A1
(en)
|
1998-01-26 |
1999-07-29 |
Walter H. Moos |
Mitochondria protecting agents for treating mitochondria associated diseases
|
|
US6737511B1
(en)
|
1999-08-16 |
2004-05-18 |
The United States Of America As Represented By The Department Of Health And Human Services |
Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
|
|
US6495522B1
(en)
|
1999-08-27 |
2002-12-17 |
Cytovia, Inc. |
Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
|
|
US6890896B1
(en)
|
1999-11-18 |
2005-05-10 |
Ceremedix, Inc. |
Compositions and methods for counteracting effects of reactive oxygen species and free radicals
|
|
US6531464B1
(en)
|
1999-12-07 |
2003-03-11 |
Inotek Pharmaceutical Corporation |
Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives
|
|
US6476048B1
(en)
|
1999-12-07 |
2002-11-05 |
Inotek Pharamaceuticals Corporation |
Substituted phenanthridinones and methods of use thereof
|
|
US6534651B2
(en)
|
2000-04-06 |
2003-03-18 |
Inotek Pharmaceuticals Corp. |
7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
|
|
GB0011095D0
(en)
|
2000-05-08 |
2000-06-28 |
Black James Foundation |
astrin and cholecystokinin receptor ligands (III)
|
|
US6521617B2
(en)
|
2000-10-13 |
2003-02-18 |
The Johns Hopkins University |
Treatment of apoptotic cell death
|
|
AU2002239595A1
(en)
|
2000-12-15 |
2002-06-24 |
Mitokor |
Compounds for altering mitochondrial function and cellular responses
|
|
US7601846B2
(en)
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
|
JP4435563B2
(ja)
|
2001-07-10 |
2010-03-17 |
バイオジェン アイデック インク |
アポトーシスプロセスの阻害および細胞性能の改善
|
|
DE10144153A1
(de)
|
2001-09-07 |
2003-03-27 |
Newfrey Llc |
Halteclip mit versetzten Rastfingern
|
|
KR20040096571A
(ko)
|
2002-02-13 |
2004-11-16 |
베쓰 이스라엘 디코니스 메디칼 센터 인크 |
혈관 질환을 치료하는 방법
|
|
CN100398519C
(zh)
|
2003-02-28 |
2008-07-02 |
伊诺泰克制药公司 |
四环苯甲酰胺衍生物及其用法
|
|
US7449464B2
(en)
|
2003-03-12 |
2008-11-11 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
EP1633362B1
(en)
|
2003-05-28 |
2012-09-26 |
Eisai Inc. |
Compounds, methods and pharmaceutical compositions for inhibiting parp
|
|
CA3024434A1
(en)
|
2004-01-23 |
2005-08-11 |
Cornell Research Foundation, Inc. |
Methods for reducing oxidative damage
|
|
TWI375673B
(en)
|
2005-04-11 |
2012-11-01 |
Abbott Lab |
1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
|
|
JP5162465B2
(ja)
|
2005-11-15 |
2013-03-13 |
アボット・ラボラトリーズ |
置換１ｈ−ベンズイミダゾール−４−カルボキサミド類は強力なｐａｒｐ阻害薬である
|
|
US7528174B2
(en)
|
2006-01-06 |
2009-05-05 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Selective targeting agents for mitochondria
|
|
EP2079699A1
(en)
*
|
2006-07-25 |
2009-07-22 |
Envivo Pharmaceuticals, Inc. |
Quinoline derivatives
|
|
US8609649B2
(en)
*
|
2007-03-20 |
2013-12-17 |
Brandeis University |
Compositions and methods for the diagnosis, treatment, and prevention of amyotrophic lateral sclerosis and related neurological diseases
|
|
US8183236B2
(en)
*
|
2007-04-12 |
2012-05-22 |
University Of Southern California |
Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
|
|
EP2148944A1
(en)
|
2007-05-25 |
2010-02-03 |
Burnham Institute for Medical Research |
Inhibitors of thapsigargin-induced cell death
|
|
US8138356B2
(en)
*
|
2007-10-16 |
2012-03-20 |
Angiogeney, Inc. |
Chemical inhibitors of inhibitors of differentiation
|
|
EP2300005A4
(en)
*
|
2008-05-28 |
2011-07-13 |
Us Of America As Represented By The Secretary Of The Army On Behalf Of U S Army Medical Res And Mate |
Small-molecule inhibitors of botulinum neurotoxins
|
|
KR20130027080A
(ko)
*
|
2010-01-06 |
2013-03-14 |
에리코, 조셉, 피. |
표적화된 약물 개발 방법 및 조성물
|
|
US8658170B2
(en)
*
|
2010-01-06 |
2014-02-25 |
Joseph P. Errico |
Combination therapy with MDM2 and EFGR inhibitors
|